Synchron
Stentrode BCI implanted through a blood vessel
Ranked #2 in Best Brain-Computer Interface Companies.
Synchron, based in New York, makes the Stentrode, a BCI delivered through the jugular vein to sit in a blood vessel over the motor cortex, avoiding open brain surgery. It raised a $200 million Series D in 2025 to prepare a pivotal trial and commercial launch.
At a glance
| Price from | Not public |
| Best for | Patients with severe paralysis seeking a less invasive implant |
From Synchron's own website.
What stands out
- No open brain surgery needed
- Moving toward a pivotal trial
Worth knowing
- Fewer electrodes than surface or penetrating arrays
- Not yet approved for sale
How it ranks
Synchron is ranked 2nd of 10 in Best Brain-Computer Interface Companies (Lister Score 96.1).
#2 in Best Brain-Computer Interface Companies · Lister Score 96.1
Synchron's $200 million Series D was led by Double Point Ventures, with ARCH Ventures, Khosla Ventures and Bezos Expeditions among existing investors..
| Rank | Best Brain-Computer Interface Companies | Score |
|---|---|---|
| 1 | Neuralink | 97.4 |
| 2 | Synchron | 96.1 |
| 3 | Precision Neuroscience | 94.8 |
| 4 | Blackrock Neurotech | 93.4 |
| 5 | Paradromics | 92.1 |
| 6 | Science Corp | 90.8 |
| 7 | Emotiv | 89.5 |
| 8 | Neurable | 88.2 |
| 9 | g.tec medical engineering | 86.9 |
| 10 | ONWARD Medical | 85.5 |
Frequently asked questions
How does Synchron rank on Lister?
Synchron is ranked 2nd of 10 in Best Brain-Computer Interface Companies (Lister Score 96.1).
Appears in
Add this badge to your site
If you work at Synchron, paste this code into your website to show where it ranks on Lister. The badge links to the ranking and updates within a day when the rank changes.